Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024

PRINCETON, N.J., Oct. 14, 2024 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2024 financial results on Monday, November 4, 2024, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. […]

$MSTR2100 Cult: Pioneering the Future of Crypto-Stock Meta Leadership

New York, NY, Oct. 14, 2024 (GLOBE NEWSWIRE) — $MSTR continues to make waves as a leader in the emerging world of crypto-stock, with exciting updates and strategic advancements that reinforce its position as a transformative force. Additionally, : $MSTR is launching its Inscriptions https://ethscriptions.com/0x49fDb8adb03e218e278536d10AE0F6535d83A9F8, a revolutionary tool designed to bridge the gap between crypto

Sharps Technology, Inc. Announces Stockholders’ Approval of Reverse Stock Split Ratio and Effective Date

NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced that it will effect a one-for-22 reverse stock split (the “reverse split”) of its common stock, par value $0.0001 per share (the “Common Stock”),

Data Monetization Market to Witness 10.70% CAGR by 2031 | SkyQuest Technology

Westford USA, Oct. 14, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that Data Monetization Market will attain the value of USD 16.98 Billion by 2031, with a CAGR of 10.70% during the forecast period (2024-2031). The rapidly increasing volume of data across the globe and increasing digital transformation are expected to fuel the growth of the

International Land Alliance Announces First Home Construction at Oasis Park

SAN DIEGO, CALIFORNIA, Oct. 14, 2024 (GLOBE NEWSWIRE) — International Land Alliance, Inc. (OTCQB:ILAL), (“ILAL” or the “Company”), an international land investment and development firm, today reported the first construction contract at its Oasis Park Resort. The Company opened up sales at its Oasis Park Resort last quarter, a master planned community located just 8KM

NewGenIvf Receives Nasdaq Notification Regarding Minimum Bid Price

BANGKOK, Oct. 14, 2024 (GLOBE NEWSWIRE) — NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), today announced that on October 8, 2024, the Company received a letter (the “Deficiency Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is currently not in compliance with the

Golden Sun Health Technology Group Limited Announces Annual General Meeting Results

SHANGHAI, Oct. 14, 2024 (GLOBE NEWSWIRE) — Golden Sun Health Technology Group Limited, formerly known as Golden Sun Education Group Limited (the “Company” or “Golden Sun”) (Nasdaq: GSUN), a provider of tutorial services in China, today announced the results of its annual general meeting of shareholders (the “AGM”) held in Shanghai on October 8, 2024.

Yoshitsu Co., Ltd Announces Plan to Adopt New Corporate Name “Tokyo Lifestyle Co., Ltd.”

TOKYO, Oct. 14, 2024 (GLOBE NEWSWIRE) — Yoshitsu Co., Ltd (“Yoshitsu” or the “Company”) (Nasdaq: TKLF), a retailer and wholesaler of Japanese beauty and health products, sundry products, luxury products, electronic products and other products in Hong Kong, Japan, North America, and the United Kingdom, today announced plans to change its corporate name to “Tokyo

LifeVantage Introduces the MindBody GLP-1 System(TM) Transforming Weight Management into a Sustainable Lifestyle

Met With High Demand, the Dual-Product System is Clinically Shown to Increase GLP-1 by 140% on average to Balance Hunger Hormones and Reduce Cravings, Supporting Sustainable Weight and Visceral Fat Loss While Maintaining Muscle â?¡Î© SALT LAKE CITY, Oct. 14, 2024 (GLOBE NEWSWIRE) — LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with

Belite Bio Announces Presentations at the American Academy of Ophthalmology 2024 Annual Meeting

SAN DIEGO, Oct. 14, 2024 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the Company will present data from its completed Phase II adolescent Stargardt disease trial

Scroll to Top